This is a non-core endpoint: only basic statistics are computed.
L02BX Other hormone antagonists and related agents
RX_L02BX
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
L02BX
1 out of 7 registries used, show all original rules.
1396
Check minimum number of events
Min. number of events
3
1396
Include endpoints None
1396
Remove individuals based on genotype QC
1341
RX_L02BX
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF3
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
L02BX Other hormone antagonists and related agents
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion (controls excluding all cancers)
- Any reimbursement code in KELA
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1341 | - | 1341 |
| Unadjusted prevalence (%) | 0.33 | - | 0.74 |
| Mean age at first event (years) | 72.95 | - | 72.95 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: RX_L02BX – L02BX Other hormone antagonists and related agents
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after L02BX Other hormone antagonists and related agents
↥Endpoint not on priority list, no data to show.